The Netherlands Cardiovascular Devices Market is expected to register a CAGR of 3.8% during the forecast period. The major factors driving the growth of the market in the Netherlands are due to technological advancements, increasing cases of cardiovascular diseases, and increased adoption of minimally invasive procedures.
In the Netherlands, Harteraad (Heartcounsel), is the patient organization for people with cardiovascular disease. Harteraad aims to improve the quality of life and quality of care for the 1.4 million people with cardiovascular diseases (CVD) in the Netherlands as per European Heart Network 2018 Annual report. Furthermore, in 2018, Harteraad started three-year programs in close cooperation with the Dutch Heart Foundation, in improving heart rehabilitation and encouraging adherence to programs and advice.
Thus, owing to the above-mentioned factors the market is expected to show growth over the forecast period. However, stringent regulatory policies and the high cost of instruments and procedures are some of the major factors restraining market growth.
Key Market Trends
Electrocardiogram (ECG) is Expected to Dominate the Diagnostic And Monitoring Segment Over the Forecast Period
An electrocardiogram (ECG) records the electrical signals from the heart. It is a common and painless test used to detect heart problems and monitor the heart's health.
Currently, there are portable and compact electrocardiogram (ECG) is driving its greater adoption, especially in the home healthcare segment. Due to rising cases of cardiovascular diseases (CVD), wherein long-term ECG monitoring is necessary and with the introduction of wireless ECG, doctors can monitor and diagnose the patient remotely on time, which further fuels the market growth.
According to the European Heart Network 2018 Annual report, estimated that European Heart Network total income and expenditure spent on cardiovascular diseases in the Netherlands was around Euros 5.485,00 in 2018 and Euros 6.241,00 in 2017.
Therefore, the growing demand for minimally invasive surgeries and technological advancements is expected to drive the market in the near future.
Competitive Landscape
The Netherland Cardiovascular Devices market is consolidated competitive. The major players have established themselves in specific segments of the market. Some of the players who are currently dominating the market are Abbott Laboratories, Boston Scientific Corporation, Medtronic PLC, Cardinal Health Inc, Biotronik, Siemens Healthineers AG, Phillips Healthcare, Nihon Kohden Corporation, and GE Healthcare.
Reasons to Purchase this report:
In the Netherlands, Harteraad (Heartcounsel), is the patient organization for people with cardiovascular disease. Harteraad aims to improve the quality of life and quality of care for the 1.4 million people with cardiovascular diseases (CVD) in the Netherlands as per European Heart Network 2018 Annual report. Furthermore, in 2018, Harteraad started three-year programs in close cooperation with the Dutch Heart Foundation, in improving heart rehabilitation and encouraging adherence to programs and advice.
Thus, owing to the above-mentioned factors the market is expected to show growth over the forecast period. However, stringent regulatory policies and the high cost of instruments and procedures are some of the major factors restraining market growth.
Key Market Trends
Electrocardiogram (ECG) is Expected to Dominate the Diagnostic And Monitoring Segment Over the Forecast Period
An electrocardiogram (ECG) records the electrical signals from the heart. It is a common and painless test used to detect heart problems and monitor the heart's health.
Currently, there are portable and compact electrocardiogram (ECG) is driving its greater adoption, especially in the home healthcare segment. Due to rising cases of cardiovascular diseases (CVD), wherein long-term ECG monitoring is necessary and with the introduction of wireless ECG, doctors can monitor and diagnose the patient remotely on time, which further fuels the market growth.
According to the European Heart Network 2018 Annual report, estimated that European Heart Network total income and expenditure spent on cardiovascular diseases in the Netherlands was around Euros 5.485,00 in 2018 and Euros 6.241,00 in 2017.
Therefore, the growing demand for minimally invasive surgeries and technological advancements is expected to drive the market in the near future.
Competitive Landscape
The Netherland Cardiovascular Devices market is consolidated competitive. The major players have established themselves in specific segments of the market. Some of the players who are currently dominating the market are Abbott Laboratories, Boston Scientific Corporation, Medtronic PLC, Cardinal Health Inc, Biotronik, Siemens Healthineers AG, Phillips Healthcare, Nihon Kohden Corporation, and GE Healthcare.
Reasons to Purchase this report:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
Table of Contents
1 INTRODUCTION
4 MARKET DYNAMICS
5 MARKET SEGMENTATION
6 COMPETITIVE LANDSCAPE
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- Boston Scientific Corporation
- Medtronic PLC
- Cardinal Health Inc
- Biotronik
- Siemens Healthineers AG
- Phillips Healthcare
- Nihon Kohden Corporation
- GE Healthcare
Methodology
LOADING...
